These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 18565316

  • 1. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review].
    Aziz M, Skougaard K, Kamby C, Nielsen DL.
    Ugeskr Laeger; 2008 Jun 16; 170(25):2248-52. PubMed ID: 18565316
    [No Abstract] [Full Text] [Related]

  • 2. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
    Tuma RS.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):86-7. PubMed ID: 16418506
    [No Abstract] [Full Text] [Related]

  • 3. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul 18; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 4. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W.
    MMW Fortschr Med; 2006 Mar 23; 148(12):10. PubMed ID: 16625996
    [No Abstract] [Full Text] [Related]

  • 5. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A, Ribelles N, Márquez A, Pérez-Ruiz E, Alba E.
    J Clin Oncol; 2009 Dec 10; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract] [Full Text] [Related]

  • 6. Aromatase inhibitors for early breast cancer therapy: a choice of effective treatment strategies.
    Dixon JM, Bundred N.
    Eur J Surg Oncol; 2006 Mar 10; 32(2):123-5. PubMed ID: 16380226
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
    Ryan PD, Goss PE.
    Nat Clin Pract Oncol; 2005 Dec 10; 2(12):596-7. PubMed ID: 16341095
    [No Abstract] [Full Text] [Related]

  • 9. Current controversies in extended adjuvant endocrine therapy for early breast cancer.
    Snoj N, Paridaens R, Cufer T.
    Curr Opin Oncol; 2008 Nov 10; 20(6):627-33. PubMed ID: 18841043
    [Abstract] [Full Text] [Related]

  • 10. Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment.
    Aksoy S, Dizdar O, Altundag K.
    Breast; 2008 Oct 10; 17(5):433-5. PubMed ID: 18565752
    [No Abstract] [Full Text] [Related]

  • 11. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E.
    Clin Adv Hematol Oncol; 2008 Aug 10; 6(8):573-4. PubMed ID: 18820598
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hormonal therapy with aromatase inhibitor in advanced breast cancer].
    Vrbanec D, Belev B, Pavlinić-Diminić V, Pezerović D, Dusper B, Plestina S, Unusić J.
    Lijec Vjesn; 1998 Aug 10; 120(10-11):315-8. PubMed ID: 19658346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.
    J Natl Cancer Inst; 2008 Oct 01; 100(19):1380-8. PubMed ID: 18812550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M, Yamashiro H, Tsuji W.
    Breast Cancer; 2009 Oct 01; 16(3):207-18. PubMed ID: 19259765
    [Abstract] [Full Text] [Related]

  • 18. Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.
    Buzdar AU, Cuzick J.
    J Clin Oncol; 2005 Nov 20; 23(33):8544-6; author reply 8546-7. PubMed ID: 16293888
    [No Abstract] [Full Text] [Related]

  • 19. [Hormonal therapy in breast cancer].
    Espinós J, Reyna C, de la Cruz S, Oiler C, Hernández A, Fernández Hidalgo O, Santisteban M, García Foncillas J.
    Rev Med Univ Navarra; 2008 Nov 20; 52(1):40-8. PubMed ID: 18578196
    [Abstract] [Full Text] [Related]

  • 20. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT.
    Breast Cancer Res Treat; 2008 Dec 20; 112 Suppl 1():25-34. PubMed ID: 19101792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.